Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 138.99M | 138.99M | 144.63M | 155.23M | 214.00M | 200.50M |
Gross Profit | 80.45M | 80.45M | 35.09M | 47.77M | 90.80M | 87.48M |
EBITDA | -6.99M | -6.99M | -4.92M | 3.10M | 7.44M | 5.98M |
Net Income | -15.04M | -15.04M | -15.99M | -5.06M | 333.00K | -5.37M |
Balance Sheet | ||||||
Total Assets | 117.21M | 117.21M | 146.90M | 190.06M | 215.76M | 199.59M |
Cash, Cash Equivalents and Short-Term Investments | 9.48M | 9.48M | 24.77M | 7.03M | 13.14M | 7.35M |
Total Debt | 7.30M | 7.30M | 19.85M | 25.45M | 29.38M | 20.93M |
Total Liabilities | 44.23M | 44.23M | 57.26M | 80.61M | 94.95M | 84.96M |
Stockholders Equity | 72.98M | 72.98M | 89.64M | 109.45M | 120.81M | 114.62M |
Cash Flow | ||||||
Free Cash Flow | 1.57M | 1.57M | 9.64M | 4.70M | 16.32M | 168.00K |
Operating Cash Flow | 2.21M | 2.21M | 12.34M | 6.55M | 18.57M | 2.69M |
Investing Cash Flow | -3.62M | -3.62M | 16.29M | -1.85M | -2.25M | -31.80M |
Financing Cash Flow | -13.91M | -13.91M | -10.90M | -10.91M | -10.59M | 29.42M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | AU$31.73M | 6.04 | 14.70% | 1.61% | 6.89% | 607.27% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | AU$102.65M | 129.63 | 1.90% | ― | 1.58% | -65.09% | |
47 Neutral | €38.87M | ― | -20.06% | 8.87% | -3.91% | 5.94% | |
47 Neutral | AU$35.49M | ― | -24.80% | ― | 2.35% | 95.03% | |
46 Neutral | €8.86M | ― | -22.96% | 109.38% | -25.16% | 77.62% | |
30 Underperform | $3.15M | ― | ― | ― | 12.92% | 34.21% |
McPherson’s Limited has reported expected revenue of $139 million for FY25, with four out of five core brands achieving revenue growth despite challenging conditions. The company has transitioned to a new operating model involving third-party warehousing and pharmacy wholesaler partnerships, which is expected to unlock EBIT benefits of $4 to $5 million annually. This strategic shift is aimed at supporting future growth and enhancing brand investment, positioning McPherson’s for improved operational performance in FY26.